Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel C Mok

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studiesKristin K Zorn, Amir A Jazaeri, Christopher S Awtrey, et al.
Disease Markers|August 24, 2004
Blood and urine markers for ovarian cancer: a comprehensive reviewKathryn L Terry, Patrick M Sluss, Steven J Skates, et al.
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.
Cancer Research|August 17, 2006
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivoKwan-Sik Kim, Saubhik Sengupta, Michael Berk, et al.
Oncotarget|February 16, 2017
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cellsTsz-Lun Yeung, Cecilia S Leung, Kwong-Kwok Wong, et al.
Nature Medicine|April 15, 2003
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumorsToshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Aberrant promoter methylation of SPARC in ovarian cancerMatthew J Socha, Neveen Said, Yanshan Dai, et al.
American Journal of Physiology. Cell Physiology|July 31, 2015
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer MetastasisTsz-Lun Yeung, Cecilia S Leung, Kay-Pong Yip, et al.
Journal of Ovarian Research|April 1, 2011
Differential hRad17 expression by histologic subtype of ovarian cancerJennifer L Young, E Colin Koon, Joseph Kwong, et al.
Human Pathology|September 26, 2006
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organsSadako Nishimura, Hiroshi Tsuda, Kiyoshi Ito, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studiesKristin K Zorn, Amir A Jazaeri, Christopher S Awtrey, et al.
Disease Markers|August 24, 2004
Blood and urine markers for ovarian cancer: a comprehensive reviewKathryn L Terry, Patrick M Sluss, Steven J Skates, et al.
Gynecologic Oncology|July 13, 2010
Up-regulation of stromal versican expression in advanced stage serous ovarian cancerSue Ghosh, Lina Albitar, Richard LeBaron, et al.
Cancer Research|August 17, 2006
Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivoKwan-Sik Kim, Saubhik Sengupta, Michael Berk, et al.
Oncotarget|February 16, 2017
ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cellsTsz-Lun Yeung, Cecilia S Leung, Kwong-Kwok Wong, et al.
Nature Medicine|April 15, 2003
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumorsToshiyasu Taniguchi, Marc Tischkowitz, Najim Ameziane, et al.
Neoplasia (New York, N.Y.)|January 30, 2009
Aberrant promoter methylation of SPARC in ovarian cancerMatthew J Socha, Neveen Said, Yanshan Dai, et al.
American Journal of Physiology. Cell Physiology|July 31, 2015
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer MetastasisTsz-Lun Yeung, Cecilia S Leung, Kay-Pong Yip, et al.
Journal of Ovarian Research|April 1, 2011
Differential hRad17 expression by histologic subtype of ovarian cancerJennifer L Young, E Colin Koon, Joseph Kwong, et al.
Human Pathology|September 26, 2006
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organsSadako Nishimura, Hiroshi Tsuda, Kiyoshi Ito, et al.
Pageof 15